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A cancer cell is characterized by autonomous 
gtowth regulation and metastasizing potential. 
Autonomous growth is thought to be due to de-
fects in the signalling pathway for, and in the 
control of cell division. These defects are inher-
itable, so it must be assumed that the DNA of a 
cancer cell is irreversibly altered in the base se-
quence andfor gene function or expression. The 
critical genes are called "oncogenes" if the un-
controlled activity of the gene product confers on 
the cell the cancerous phenotype. Alternatively, if 
the presence of the gene product is required for 
normal growth control, the gene is called a "tu-
mor suppressor gene". In this case, loss of the 
function can result in malignant transformation. 
All chemical and physical interactions with DNA 
entail the possibility to "activate" an oncogene or 
"inactivate" a tumor suppressor gene. In radia-
tion carcinogenesis, hydroxylation of DNA nu-
cleotides and strand breaks are the predominant 
mechanisms of genotoxic action. In chemical car-
cinogenesis, the most important primary lesion is 
covalent binding of the carcinogen to DNA to 
form carcinogen-nucleotide adducts. Most well-
known genotoxic carcinogens, such as aflatoxins, 
polynuclear aromatic hydrocarbons, aromatic 
amines and nitrosamines, are chemically inert 
and highly lipophilic. Once in the organism, they 
have to be metabolized to become excretable. 
During this process of enzymatic "activation", 
chemically reactive intermediate metabolites are 
formed ( epoxides, nitronium ions, alkyl diazon-
ium ions). Most of these are inactivated by reac-
tion with uncritical target molecules and only a 
minute but important fraction ends up in a reac-
tion with DNA. 
Testing chemieals for carcinogenic activity in-
volves life-long administration of the test com-
pound to rats and mice and histopathological 
analysis of about 40 different organs and tissues. 
Group size in general is 50 animals per dose and 
sex. The highest dose Ievel is much higher than 
any human exposure, as an attempt to compen-
sate for the lower nurober of exposed individuals. 
As a consequence, the results have to be extra-
polated to Jow dose Ievels. 
In this paper, the biochemical and biological 
mechanisms which determine the dose-response 
relationship will be discussed. Conclusions will 
be drawn for the risk assessment of low-dose ex-
posure of human populations. 
Dose-response relationship for 
genotoxic carcinogens 
DNA adducts as afunction of dose 
The processes and reactions which result in DNA-
carcinogen adducts include diffusions, enzymatic 
activation to reactive intermediates, and enzy-
matic or non-enzymatic reactions of the inter-
mediates with target and non-target molecules. At 
lowest exposure dose levels, when all concentra-
tions are far below the Michaelis concentrations 
of the enzymatic reactions, the rate of formation 
of DNA adducts is expected to be proportional 
to dose (Fig. 1 : top chart; low-dose range). This 
situation has been found with DN A adducts 
formed in rat liver after repeated administration 
of aflatoxin B1 in the dose range of 1 ng/kg to 
10 ~g/kg body weight per day 1 . 
DNAADDUCTS 
SUPERLINEAR 
DUETO: 
Saturation of inactivation OR 
Saturation of DNA repair 
GENETIC CHANGES 
SUPERLINEAR 
DUE TO: 
CARCINOGEN DOSE 
Stimulation of DNA replication 
(regenerative cell division 
due to high-dose cytotoxicity) 
DNAADDUCTS 
Fig. 1. Schematic illustration of the dose-response relationship 
for two aspects of the process of carcinogenesis by genotoxic 
agents. Top chart: Relationship between exposure dose and 
level of DNA adducts. Bottom chart: Relationship between 
the primary DNA lesion (DNA adducts) and the number of 
mutations (genetic changes). 
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At intermediate and high dose Ievels, Saturation 
of enzymatic activities can result in nonlinearities 
of the dose-response curve 2 . For instance, when 
the enzymatic inactivation of the reactive inter-
mediate becomes saturated at a given concentra-
tion, a further increase of the dose will result in 
an overproportional rate of DNA-adduct forma-
tion. The dose-response curve will be curved up-
wards (Fig. 1 : top chart; sublinearity at inter-
mediate dose range). The sublinearity seen for 
the formation of DNA-protein crosslinks.with in-
creasing doses of formaldehyde has been attrib-
. uted to the saturation of a glutathione-depen-
dent pathway for formaldehyde detoxication. The 
same will happen if the DNA repair becomes 
saturated at higher Ievels of DNA darnage (exam-
ple: repair of 0 6-methylguanine formed by me-
thylating agents). Alternatively, if the enzymatic 
activation is saturated, a flattening-out of the 
dose-response curve results (Fig. 1 : top chart; 
high dose range). This situation is exemplified 
with vinyl chloride where both enzymatic epoxi-
dation and tumor induction flatten out above 
500 ppm inhalation exposure. 
In summary, the dose-response relationship for 
the formation of DNA-carcinogen adducts is ex-
pected to be linear at the lowest exposure Ievels. 
At intermediate and high dose Ievels, however, 
a number of possibilities exist for the introduc-
tion of nonlinearities into the shape of the dose-
response curve. A comparison with radiation-
induced DNA darnage shows partial analogy: 
while radiation does not require enzymatic 
activation to darnage DNA or to generate reactive 
molecules, sublinearities due to a saturation of 
the inactivation of reactive molecules or of DNA 
repair are also expected for ionizing radiation. 
Mutations as a function of dose 
Formation of DNA-carcinogen adducts is not a 
sufficient condition for carcinogenesis if the re-
pair is error-free. Only upon DNA replication can 
a DNA adduct result in a heritable mutation in 
a daughter strand. The rate of mutations from 
DNA adducts is therefore dependent on the rela-
tive rates of DNA repair and DNA replication. 
High dose Ievels of genotoxic agents are expected 
to reduce cellular life span because the chemically 
reactive metabolites of genotoxic carcinogens do 
not only bind to DNA but also to other cellular 
components, predominantly protein. Cytotoxicity 
and necroses, followed by regenerative hyper-
plasia, represent a condition characterized by an 
increased rate of cell division. With this shorten-
ing of the cell cycle, the time available for DNA 
repair is reduced so that a larger nurober of 
DNA adducts can be fixed as mutations in the 
daughter cell. This phenomenon will result in a 
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sublinear dose-response relationship (Fig. 1 : bot-
tarn chart). 
According to the rules set by some regulatory 
agencies, the highest dose Ievel used in a standard 
rodent bioassay for carcinogenicity has to show 
signs of general toxicity. In the case of a positive 
result for turnor induction it is therefore impor-
tant to investigate whether the target organ for 
neoplasia was also a target organ for cytotoxicity. 
Ifthis is the case, reduction ofthe dose to non-toxic 
Ievels might dramatically reduce the risk of induced 
tumor formation 3 • 
Tumors as a consequence of multiple mutations 
Malignant transformation of a normal stem cell 
requires more than one genetic change. In a two-
stage situation, the probability of reaching the 
malignant stage can be approximated by the 
product of the probabilities of the individual 
steps 4 • If the mutations derived from DNA ad-
ducts aceeierate both steps, the overall effect is 
the product of the dose-response curves for the 
individual steps. With a linear relationship for 
each single step, a quadratic dose dependence 
would result for the entire process. 
Conc/usions 
The three aspects discussed above illustrate that 
nonlinear parts in the dose-response relationships 
are the rule rather than the exception for tumors 
in a standard animal bioassay for carcinogenic-
ity with maximum tolerated doses of genotoxic 
carcinogens 5 • For an extrapolation to low dose, 
therefore, each case must be evaluated for non-
linearities due to i), the steady-state Ievel of DNA 
adducts, ii), target organ toxicity, iii), the aspect 
of the multi-stage acceleration of the process of 
malignant transformation by the carcinogen in-
vestigated. 
Population heterogeneity: 
Linearizing the dose-response curve 
In the light of the, aspects discussed above it is 
astanishing at first glance that only two epide-
miological investigations in humans show a de-
viation from a linear dose-response relationship, 
i.e. the induction of lung cancer in British physi-
cians by cigarette smoking and the induction of 
bladder cancer in men occupationally exposed to 
ß-naphthylamine 5 . In a number of additional 
epidemiological investigations, nonlinear tenns 
are either not significant, or are based on mis-
leading simplifications in exposure assessment 5 • 
This lack of higher-arder terms in epidemiologial 
sturlies has been attributed to a systematic bias 
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from the inaccurate measurement of the extent 
to which target cells are affected 6 • The explana-
tion suggested here is based on the heterogeneity 
of the human population. It was shown in the 
preceding section that the frequency of carcino-
gen-induced mutations is dependent on the steady-
state Ievel of promutagenic DNA adducts and the 
rate of DNA replication. The DNA adduct Ievel 
itself is dependent on the activity of a nurober of 
enzymes involved in the formation and inactiva-
tion of reactive intermediates as well as in DNA 
repair. While the animals used in a standard bio-
assay for carcinogenicity are homogeneaus for 
these enzymatic activities, the interindividual 
variation in the human population is enormaus 7 • 
Since the activity of these enzymes is genetically 
controlled, distinct subpopulations can be dis-
cerned which will differ in their susceptibility 
towards a chemical carcinogen. The following 
example illustrates the situation. 
The hybrid mouse B6C3F1 is often used for ani-
mal bioassays on carcinogenicity. It derives from 
the two inbred strains C57BL/6N and C3HjHeN 
and therefore is genetically heterozygous. Let 
us assume that the gene coding for the enzyme 
glutathione transferase (GST) is weakly active 
in the C3 mice (genotype aa) and highly active 
in the Black 6 mice (genotype AA). The hetero-
zygous F1 hybrid will have genetype aA and will 
exhibit an intermediate enzyme activity. Let us 
now assume that, in this strain, the dose-response 
curve for tumor induction exhibits a steep sub-
linearity in that dose range where the enzymatic 
inactivation of the epoxide by glutathione trans-
ferase becomes saturated, and cytotoxicity and 
regenerative hyperplasia become tumor-pro-
moting factors (Fig. 2: top chart). If we now out-
cross the hybrid aA mice inter se, the progeny 
will show genotypes aa, aA, AA in a ratio 1:2:1, 
and the different inactivation potential conveyed 
by the OST activity will result in three sub-
populations with different tolerated carcinogen 
dose Ievels (Fig. 2: middle chart). If this line of 
thought is expanded to a larger number of en-
zymes, and if modulation of the enzyme activities 
by Iife-style is allowed, a quasi-linear shape of 
the dose-response relationship will result (Fig. 2: 
bottom chart). 
Endogenous DNA damage: 
Spontaneous tumor formation 
It is often assumed that cancer could be pre-
vented if all exogenaus genotoxic carcinogens 
could be eliminated. In centrast to this view is 
the understanding the DNA is constantly being 
damaged by endogenaus and unavoidable agents 
and processes 8 • F or instance, endogenaus elec-
trophiles are found with the CO-substrates of 
physiological transfer reactions (e.g., S-adenosyl- · 
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Fig. 2. Cumulative tumor incidence in populations with in-
creasing heterogeneity for enzyme activities critically involved 
in the formation or persistence of DNA adducts. Top chart: 
heterozygous situation, typical for a hybrid strain. Middle 
chart: monogenetic polymorphism. Bottom chart: suscepti-
bility determined by multiple gene loci and modulated by 
Iüe-style. 
methionine for methylations), with aldehyde 
groups (glyceraldehyde-3-phosphate, formalde-
hyde, open forms of reducing sugars), or with 
metabolites of endogenously . formed nitrose 
compounds. Radical-forming reactions ; include 
leakage . of · the superoxide anion radical from 
cytochromes and redox cycles, the Fenton reac-
tion which generates hydroxyl radicals from 
endogenaus hydrogen peroxide. DNA instability 
due to spontaneaus deaminations and depuri-
nations as weH as errors in DNA replication in 
the presence of mutagenic metal ions represent a 
third important class of endogenaus genotoxic 
processes. 
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The postulated endogenaus genotoxicity could 
form the mechanistic basis for what is called 
"spontaneaus" tumor incidence. This concept 
implies that the process of malignant transfor-
mation is inevitable. Individuals will show differ-
ent rates of this process which, in turn, defines the 
latency period, i.e., the length of the tumor-free 
life. 
Loss of tumor-free life span as a function of dose 
If we assume that all individuals sooner or later 
develop a tumor spontaneously, the exposure to 
an exogenous carcinogen "reduces the tumor-free 
life span". While a low dose is expected to reduce 
the tumor-free life span only slightly, a large dose 
would do so dramatically. The dose-effect rela-
tionship could be evaluated accordingly. 
This approach is exemplified on the basis of the 
data collected from an experiment with 4320 
weanling female BALB/c mice treated chronical-
ly with 0, 30, 35, 45, 60, 75, 100, and 150 ppm 
2-acetylaminofluorene (AAF) admixed to the 
diet 9 • Animals which survived 1,000 days of the 
experiment were killed. Autopsy and histology of 
all animals made it possible to attribute a cause 
to all deaths. The life-shortening effects of spe-
cific causes of death were analyzed after adjust-
ing for all competing causes 9 • Figure 3 shows 
Kaplan-Meier survival curves with respect to 
death by tumors of various organs. It is obvious 
that tumors of the liver (top chart of Fig. 3) re-
sulted in an appreciable number of deaths already 
in the control group. The area shaded horizon-
tally represents 2.6 percent of the reetangle de-
fined by 100 percent of the animals living for 
1,000 days. This means that spontaneous liver 
tumors were responsible for a 2.6 percent reduc-
tion of a 1 ,000-day life span. Treatment of the 
mice with 100 ppm AAF in the diet now resulted 
in an additional reduction of the life span by 
3.9 percent (vertical shading in the top chart of 
Fig. 3). Bladder cancer, on the other band, was 
practically lacking in the controls but became an 
important cause of death in the AAF-treated 
populations (middle chart of Fig. 3). Relative to 
the tumor situation in the control animals, AAF 
therefore appears to be a specific carcinogen for 
the bladder but only an accelerating factor for the 
growth of spontaneaus liver tumors. The effect 
on reticulum cell tumors (bottom chart of Fig. 3), 
finally, is so small relative to the high incidence 
in the control group that AAF is not even said to 
be carcinogenic for this cell type. 
This type of analysis could well be used for dose-
response considerations in that the loss of sur-
vival time could be expressed as a function of 
dose. This would, for instance, mean that the 
loss of life span due to bladder cancer increases 
0.5 
0.5 
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Fig. 3. Kaplan-Meier survival curves with respect to death 
by various tumors for female BALBfc mice treated with 
2-acetylaminofluorene (AAF) added in the diet. The different 
curves relate to the different dose levels indicated in the upper 
left corner. Redrawn from Kodell et al. 9 • 
sublinearly when going from 0 to 100 to 150 ppm, 
while a different dose-response relationship is 
derived for liver tumors. This approach has a 
number of advantages over the existing analyses: 
i) It includes the element of time and ageing, 
and does not merely reflect the situation at 
one time-point. In accordance with risk per-
ception, it gives a higher weight to early-ap-
pearing tumors as compared with late-appear-
ing ones. 
ii) The effect of an exposure to an exogenaus car-
cinogen can be expressed on the basis of the 
endogenaus process leading to spontaneaus 
neoplasia. On this basis, risks of exposure to 
an exogenaus carcinogen do not have to be 
expressed as absolute values of increased tu-
mor incidence. The compound-related risk can 
be evaluated relative to an unavoidable risk. 
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Comparison with radiation carcinogenesis 
One important difference lies in the fact that ro-
dent bioassays for chemical carcinogenicity are 
always based upon life-long administration of the 
test compound, in most cases starting at the age 
of about 6 weeks. For an extrapolation to low 
dose Ievels, therefore, there is no need to intro-
duce a dose- or dose rate-reduction factor as is 
often required in radiation carcinogenesis to ex-
trapolate from single-dose experiments. 
Another difference is based on the requirement of 
metabolism for most genotoxic carcinogens. Sat-
uration and induction of the enzymes responsible 
for the activation of the chemical to a reactive 
species and for inactivation processes can Iead to 
nonlinearities in the dose-response relationship not 
expected in radiation carcinogenesis. 
Similarities are seen, however, with the back-
ground radiation and the resulting unavoidable 
DNA darnage as weil as with the idea that cell 
killing at higher radiation dose Ievels followed by 
regenerative hyperplasia in the surrounding tissue 
can result in nonlinearities of the dose-response 
relationship. The linear-quadratic shape seen in a 
number of cases might reflect this situation. 
Summary 
Formation and repair of DNA adducts from ge-
notoxic carcinogens is expected to be proportion-
al to dose as long as the rates of the enzymatic 
and non-enzymatic activation and inactivation 
reactions are all proportional to the substrate 
concentration. Deviations from linearity are ex-
pected in situations of induced and saturated ki-
netics. A sublinear shape of the dose-response 
curveis always expected at toxic dose Ievels when 
regenerative hyperplasia accelerates the fixation 
and accumulation of mutations resulting from the 
DNA adducts. In a heterogeneous population, 
however, a nonlinear dose-response curve is lin-
earized when genetic and Iife-style factors result 
in individual variability in the rates of the activa-
tion and inactivation pathways. Finally, in the 
light of the endogenous and therefore partly un-
avoidable nature of genetic damage, it is proposed 
that the cancer risk from exposure to an exogen-
ous carcinogen should be expressed as a reduc-
tion of tumor-free life span rather than in abso-
lute terms of additional cases. 
Resurne 
Relation dose-reponse des agents genotoxiques dans 
Ia cancerogenese chimique 
Le niveau d'adduits des cancerigenes chimiques 
aux nucleotides de 1' ADN est proportionnel ä la 
247 
dose pour autant que les reactions enzymatiques 
et non enzymatiques ne soient par saturees. A des 
concentrations plus elevees, il y a de nombreuses 
possibilites de deviation de la linearite, surtout en 
cas de Saturation de l'activation des cancerigenes 
et de la detoxification des metabolites electrophi-
les. A des doses toxiques, l'induction de tumeurs 
est acceleree par la division cellulaire stimulee 
par la regeneration du tissu, ce qui peut entrainer 
une relation exponentielle. Dans une population 
heterogene, les nonlinearites sont linearisees par 
les polymorphismes enzymatiques et les niveaux 
individuels des reactions de toxification et de de-
toxification. En considerant les atteintes endoge-
nes et inevitables de l'ADN, il est propose que le 
risque exogene ne soit plus exprime en nombre de 
cas additionnels mais par une reduction du temps 
de vie sans tumeur. 
Zusammenfassung 
Dosis-Wirkungsbeziehung in der chemischen Kan-
zerogenese durch gentoxische Substanzen 
Im tiefsten Dosisbereich ist die DNS-Schädigung 
durch gentoxische Kanzerogene proportional zur 
Expositionsdosis, so lange die Geschwindigkeit 
aller beteiligten enzymatischen und nichtenzyma-
tischen Reaktionen proportional zur Konzentra-
tion ist. Wird die Dosis so weit erhöht, dass En-
zyme induziert werden und/oder Reaktionen ge-
sättigt ablaufen, ergeben sich vielfältige Möglich-
keiten von nichtlinearen Kurvenverläufen. Ein 
sublinearer Verlauf ergibt sich im höheren Dosis-
bereich immer dann, wenn Zytotoxizität und re-
generative Hyperplasie die Akkumulation von 
Mutationen beschleunigen. Andererseits wird eine 
nichtlineare Dosis-Wirkungs-Kurve in heteroge-
nen Populationen geglättet, wenn die kritischen 
Enzymaktivitäten individuell unterschiedlich sind. 
Im Extremfall kann eine quasi-lineare Dosis-
Wirkungsbeziehung auch bei mechanistisch be-
gründeter Nichtlinearität anzutreffen sein. Wird 
schliesslich berücksichtigt, dass auch endogene 
gentoxische Agentien und unvermeidliche Prozesse 
die DNS schädigen, ist es sinnvoll, exogene Be-
lastungen nur als beschleunigende Faktoren eines 
spontanen Prozesses anzusehen und die Dosis-
Wirkungsbeziehung im Sinne eines Verlustes an 
tumorfreier Zeit zu analysieren. 
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